4b. Are adequate personnel (employees) available for the implementation of this
responsibility?
5a. Does the government have a method to estimate realistically the medical and
scientific needs for narcotic drugs, including for the opioid analgesics which are needed
for pain relief and palliative care?
5b. Has the government critically examined its method for assessing medical needs
for narcotic drugs, as requested by the INCB?
6. Does the government furnish annual estimates to the INCB of need
for narcotic drugs for the next year in a timely way?
[ ] Yes [ ]
No [ ] Information not available
7. If it appears that the medical need for opioid analgesics will exceed the
estimated amount which has been approved and confirmed by the INCB, is it government
policy to furnish a request for a supplementary estimate?
[ ] Yes [ ]
No [ ] Information not available
8. Does the government submit to the INCB in a timely way the required annual
statistical reports respecting production, manufacture, trade, use and stocks of narcotic
drugs?
[ ] Yes [ ]
No [ ] Information not available
9a. Has the government informed health professionals about the legal requirements
for the use of narcotic drugs, and provided an opportunity to discuss mutual concerns?
[ ] Yes [ ]
No [ ] Information not available
9b. Has the government identified and addressed concerns of health care
professionals about being investigated for prescribing opioids?
[ ] Yes [ ]
No [ ] Information not available
10. Is there cooperation between the government and health care professionals
to ensure the availability of opioid analgesics for medical and scientific purposes?
[ ] Yes [ ]
No [ ] Information not available
11. Has the government taken steps, in cooperation with licensees, to ensure that
there are no shortages of supply of opioid medications caused by inadequate procurement,
manufacture and distribution systems?
[ ] Yes [ ]
No [ ] Information not available
12. Do national drug control policies provide for the licensing of an adequate
number of individuals and entities to support a distribution system that will maximize
physical access of patients to pain relief medications?
[ ] Yes [ ]
No [ ] Information not available
13a. Has the government established a national cancer control programme to
which it allocates health care resources?
[ ] Yes [ ]
No [ ] Information not available
13b. Has the government taken steps to ensure the practice of the WHO Analgesic
Method for cancer pain relief by continuing education programmes and by its inclusion in
medical, pharmacy and nursing curriculum?
[ ] Yes [ ]
No [ ] Information not available
14. Is there terminology in national drug control policy that has the potential to
confuse the medical use of opioids for pain with drug dependence?
[ ] Yes [ ]
No [ ] Information not available
15. Are there provisions in national drug control policy that restrict the amount of
drug prescribed or the duration of treatment?
[ ] Yes [ ]
No [ ] Information not available
16. Are there prescription requirements in national drug control policy that may
unduly restrict physician and patient access to pain relief?
